Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Grace Borichevsky

Grace BorichevskyPhD candidate

 

Email grace.borichevsky@otago.ac.nz
Tel +64 3 364 0566

Research interests

Grace Borichevsky wants to understand and predict disease activity in inflammatory bowel disease.

Her PhD supervisors are Professors Tony Kettle and Richard Gearry.

^ Top of page

Publications

Swaminathan, A., Frampton, C. M., Borichevsky, G. M., Kettle, A. J., & Gearry, R. B. (2022). Response to "Evaluating discriminative accuracy of biomarkers in relation to binary study outcomes: First validate, then celebrate?" Journal of Crohn's & Colitis. Advance online publication. doi: 10.1093/ecco-jcc/jjac126

Swaminathan, A., Borichevsky, G. M., Edwards, T. S., Hirschfeld, E., Mules, T. C., Frampton, C. M., Hampton, M. B., Kettle, A. J., & Gearry, R. B. (2022). Faecal myeloperoxidase as a biomarker of endoscopic activity in inflammatory bowel disease. Journal of Crohn's & Colitis. Advance online publication. doi: 10.1093/ecco-jcc/jjac098

Swaminathan, A., Fan, D., Borichevsky, G. M., Mules, T. C., Hirschfeld, E., Frampton, C. M., Day, A. S., … Gearry, R. B. (2022). The disease severity index for inflammatory bowel disease is associated with psychological symptoms, quality of life and predicts a more complicated disease course. Alimentary Pharmacology & Therapeutics. Advance online publication. doi: 10.1111/apt.17058

Borichevsky, G., Swaminathan, A., Edwards, T., Day, A., Hampton, M., Kettle, A., & Gearry, R. (2021). Faecal myeloperoxidase is a biomarker of endoscopically active inflammatory bowel disease. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 234). Retrieved from https://www.faobmb2021.org

Mules, T. C., Swaminathan, A., Hirschfeld, E., Borichevsky, G., Frampton, C., Day, A. S., & Gearry, R. B. (2021). The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study. Alimentary Pharmacology & Therapeutics. Advance online publication. doi: 10.1111/apt.16616